Andere Sprachen Neurotech International Limited

Aktien

A2DJ19

AU000000NTI9

NTI

Markt geschlossen - Australian S.E. Andere Börsenplätze 08:10:42 02.05.2024			% 5 Tage	% 1. Jan.
0,091 ^AUD	0,00 %		+1,11 %	+31,88 %

10.04.	Neurotech International schließt Phase II/III NTIASD2-Studie für Kinder mit Autismus ab	MT
26.02.	Neurotech International Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Halbjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint	17.04.
Neurotech International Completes AU$10 Million Capital Raise	17.04.
Rice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulation	15.04.
Neurotech International Concludes Phase II/III NTIASD2 Trial for Children with Autism	10.04.
Neurotech International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26.02.
Neurotech Receives Human Research Ethics Committee Approval to Extend Autism Trial	13.02.
Neurotech's ASD Drug Trials Exceed 90 Weeks	07.02.
Neurotech International Secures Approval to Advance Cerebral Palsy Trial; Shares Rise 6%	29.01.
Neurotech International Completes Enrolment for Phase 2/3 Autism Spectrum Trial	19.12.
Neurotech International Secures Ethics Approval for Use of Autism Spectrum Medication in Adults	04.12.
Neurotech International Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023	14.11.
Retinitis Pigmentosa Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	13.11.
Butterfly Network Announces 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Using Ultrasound-on-Chip Technology	25.10.23
Neurotech International Completes Enrollment for Rett Syndrome Trial	26.09.23
Alex Gorsky Joins Neurotech's Board as Lead Director	14.09.23
Neurotech International Completes Treatment for Last Patient in Phase I/II PANDAS/PANS Clinical Trial	31.08.23
Neurotech International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30.08.23
Neurotech International Secures Ethics Approval for Clinical Trial of Neurological Medication	10.07.23
Neurotech International Secures Ethics Approval to Extend Use of Medication in Pediatric Trial	30.05.23
Neurotech International Completes Patient Recruitment for Neuropsychiatric Disorder Treatment Trial	03.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Neurotech International Limited

Aktien

A2DJ19

AU000000NTI9

NTI

Andere Sprachen

Filter